1057 HBM7008, a first-in-class bispecific antibody targeting both B7-H4 and 4–1BB, exhibits robust anti-tumor immunity and low toxicity through B7-H4-directed 4–1BB activation

Bing Huang, Fangfang Du,Xiaocheng Lv, Jianxun Zhao, Fei Chen, Zailian Lu,Yang Zhang,Victor Chen,Xin Gan,Jiuqiao Zhao,Yun He,Xiaodong Wu,Yiping Rong

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要